Yuki Koichi, Scholl Rebecca
Department of Anesthesiology, Critical Care and Pain Medicine, Cardiac Anesthesia Division, Boston Children's Hospital, Massachusetts, USA.
Department of Anesthesia, Harvard Medical School, Boston, Massachusetts, USA.
Transl Perioper Pain Med. 2020;7(2):185-189. Epub 2020 Jan 18.
Cases of cardiac arrest after administration of neostigmine as a neuromuscular reversal agent have been reported in the literature. Sugammadex is a new neuromuscular reversal agent that acts via a different mechanism than acetylcholinesterase inhibitors. Here we reviewed the currently available literature on the use of sugammadex and potential considerations of using sugammadex in patients with a history of heart transplantation. Based on our currently available information, sugammadex administration in heart transplant patients should warrant similar caution and preparation for cardiovascular collapse as acetylcholinesterase inhibitors.
文献中已报道了使用新斯的明作为神经肌肉阻滞剂后发生心脏骤停的病例。舒更葡糖钠是一种新型神经肌肉阻滞剂,其作用机制与乙酰胆碱酯酶抑制剂不同。在此,我们回顾了目前关于舒更葡糖钠使用的文献,以及在有心脏移植病史的患者中使用舒更葡糖钠的潜在注意事项。根据我们目前掌握的信息,在心脏移植患者中使用舒更葡糖钠时,应像使用乙酰胆碱酯酶抑制剂一样,对心血管虚脱给予同样的谨慎关注和做好相应准备。